Search

Your search keyword '"Markova, Jana"' showing total 266 results

Search Constraints

Start Over You searched for: Author "Markova, Jana" Remove constraint Author: "Markova, Jana"
266 results on '"Markova, Jana"'

Search Results

1. PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial

2. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)

8. PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

10. Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group

11. Probabilistic Analysis of Corrosion Rates and Degradation of Weathering Steel Bridges.

15. Uncertainties of Crack Width Models

16. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

17. P047: Predictive role of the Hodgkin lymphoma-associated cytokines: a prospective study of the Czech Hodgkin Study Group

18. P023: PET2-adapted approach after 2 cycles of ABVD is comparable to 2 cycles of BEACOPP escalated and 2 cycles of ABVD and irradiation in early unfavorable Hodgkin lymphoma

23. Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

25. Is It Better to Start Treatment with ABVD and Continue with PET2-Adapted Approach or Should We Use 2 Cycles of Beacopp Escalated and 2 Cycles of ABVD and Irradiation in Early Unfavorable Hodgkin Lymphoma?

31. Nature of frequent deletions in CEBPA

34. Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

37. Thermal design of structures and the changing climate

38. Health-Related Quality of Life in Patients With Hodgkin Lymphoma: A Longitudinal Analysis of the German Hodgkin Study Group

41. Dose-Intensification in Early Unfavorable Hodgkin Lymphoma: Long-Term Follow up of the German Hodgkin Study Group (GHSG) HD14 Trial

42. State of harmonised use of the Eurocodes

43. Preparing a European standard for ice loads on structures

46. The implementation of the Eurocodes in the National Regulatory Framework

47. High resolution biogenic global emission inventory for the time period 2000-2019 for air quality modelling.

48. Reliability of Structural Members Designed with the Eurocodes NDPs Selected by EU and EFTA Member States

50. Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma

Catalog

Books, media, physical & digital resources